4Reynolds CP,Lemons RS. Retinoid therapy of childhood cancer. Hematol Oncol Clin North Am,2001,15(5): 867-910.
5Ross SA, McCaffery PJ, Drager UC, et al. Retinoids in embryonal development. Physiol Rev, 2000,80(3): 1021-1054.
6Kastner P,Chan S. Function of RARalpha during the maturation of neut rophils. Oncogene, 2001,20 (49): 7178-7185.
7Mahon FX,Chahine H,Barbot C,et al. All-trans retinoic acid potentiates the inhibitory effects of interferon alpha on chronic myeloid leukemia progenitors in vitro. Leukemia, 1997,11(5) :667-673.
8Zheng A,Savolainen ER, Koistinen P. All-trans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia. Leuk Res,1996,20(3) :243-248.
9Zhu J, Lallemand-Breitenbach V, de-The H. Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission. Oncogene, 2001,20(49):7257-7265.
10Sieving,P A; Chaudhry, P; Kondo, M et al. Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc-Natl-Acad-Sci-U-S-A. 2001 Feb 13, 98(4): 1835
